Stroke/Vascular Neurology News

Among patients with ischemic stroke and mismatch imaging profiles, the performance of endovascular thrombectomy correlated with improvements in clinical outcomes, according to a study published in JAMA Neurology.

Lumosa Therapeutics announced its novel agent for patients with acute ischemic stroke met the primary safety endpoint in a phase 2 trial.

Metabolic syndrome demonstrated significant correlations with both stroke recurrence and all-cause mortality, according to the results of a meta-analysis of 13 cohort studies with nearly 60,000 participants published in Neurology.

Among patients who underwent left ventricular arrhythmia ablation with a radiofrequency catheter, direct oral anticoagulants were superior to aspirin in preventing cerebrovascular events, according to the results of the STROKE-VT trial.

Marijuana use was not associated with risk for ischemic stroke among young adults compared with never users, according to research published in Stroke.

Individuals with late-onset epilepsy experienced an increased risk for death compared with individuals without epilepsy, even after adjustment for comorbidities, according to findings published in Neurology.

Among older adults, all measures of ambulatory BP were associated with risk for stroke while office diastolic BP was only weakly associated, and central BP measures were not associated with stroke at all, researchers reported.

Patients who had a stroke had steeper declines in cognitive and daily functioning up to 10 years prior to their first stroke compared with those who never had a stroke.

Patients with higher or lower BMIs faced significantly greater risks for global cognitive function and frontal domain performances following an ischemic stroke, according to a study published in Scientific Reports.

The American Heart Association, the Society of Vascular and Interventional Neurology and John Wiley & Sons announced the launch of Stroke: Vascular and Interventional Neurology, a new peer-reviewed, open access journal.